Singh, K., Hotchkiss, K. M., Parney, I. F., De Groot, J., Sahebjam, S., Sanai, N., … Khasraw, M. (2023). Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nat Med, 29(10), 2402–2405. https://doi.org/10.1038/s41591-023-02464-8

Singh, Kirit, Kelly M. Hotchkiss, Ian F. Parney, John De Groot, Solmaz Sahebjam, Nader Sanai, Michael Platten, et al. “Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.” Nat Med 29, no. 10 (October 2023): 2402–5. https://doi.org/10.1038/s41591-023-02464-8.

Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N, et al. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nat Med. 2023 Oct;29(10):2402–5.

Singh, Kirit, et al. “Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.” Nat Med, vol. 29, no. 10, Oct. 2023, pp. 2402–05. Pubmed, doi:10.1038/s41591-023-02464-8.

Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N, Platten M, Galanis E, Lim M, Wen PY, Minniti G, Colman H, Cloughesy TF, Mehta MP, Geurts M, Arrillaga-Romany I, Desjardins A, Tanner K, Short S, Arons D, Duke E, Wick W, Bagley SJ, Ashley DM, Kumthekar P, Verhaak R, Chalmers AJ, Patel AP, Watts C, Fecci PE, Batchelor TT, Weller M, Vogelbaum MA, Preusser M, Berger MS, Khasraw M. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nat Med. 2023 Oct;29(10):2402–2405.